Lataa...

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy

The constitutive activation of signal transducer and activator of transcription 3 (STAT3) is frequently detected in clinical incidences of hepatocellular carcinoma (HCC) but not in normal human hepatocytes. STAT3 signaling plays pivotal roles in angiogenesis, survival, metastasis, and growth of HCC....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zuo, Mingxin, Li, Chenglong, Lin, Jiayuh, Javle, Milind
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4484430/
https://ncbi.nlm.nih.gov/pubmed/25883212
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!